{"schema_version":"secwatch.filing_event.v1","accession":"0001412408-21-000075","form_type":"8-K","ticker":"PHR","cik":"0001412408","company_name":"Phreesia, Inc.","filed_at":"2021-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.995203+00:00","generated_at":"2026-06-29T06:24:59.774207+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Phreesia Q2 revenue up 46% to $51M; net loss widens to $24.4M; raises FY22 outlook","bullets":["Revenue $51.0M (+46% YoY); avg provider clients 1,987 (+19%); ARPU $19,720 (+14%).","Net loss $24.4M (diluted EPS -$0.48) vs $6.4M loss; Adj. EBITDA -$11.0M vs +$1.2M.","Cash $439.9M after $245.8M follow-on offering; FY22 revenue guidance raised to $195-198M.","Life sciences revenue $11.8M (nearly doubled); payment processing fees $16.3M (+38%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001412408-21-000075","json":"https://secwatch.observer/filing/0001412408-21-000075.json","markdown":"https://secwatch.observer/filing/0001412408-21-000075.md","text":"https://secwatch.observer/filing/0001412408-21-000075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412408/000141240821000075/0001412408-21-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412408/000141240821000075/phr-20210901.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T06:24:59.774207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}